pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • pre_registration
    gedatolisib
    gedatolisib
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$CELC Celcuity Inc.
  • Phase 2
    gedeptin
    Nasopharyngeal Cancer$GOVX GeoVax Labs, Inc.
  • Marketed
    gefitinib
    Gefitinib
    Non-Small Cell Lung Cancer Actavis Laboratories NY Inc (Inactive)
  • pre_registration
← prev
page 182 of 231
next →
Pain89
Neurology1
gefurulimab
gefurulimab
Myasthenia Gravis
Alexion Pharmaceuticals Inc
  • Phase 1
    gemcitabine
    Avgemsi (gemcitabine)
    Pancreatic Cancer Continuity Biosciences LLC
  • Marketed
    gemfibrozil
    Gemfibrozil
    Hyperlipidemia Nivagen Pharmaceuticals Inc
  • Phase 2
    gemlapodect
    gemlapodect
    Stammering (Stuttering) Noema Pharma AG
  • Phase 2
    gemogenovatucel-T
    Vigil (gemogenovatucel-T)
    Endometrial Cancer Gradalis Inc
  • Marketed
    gemtuzumab ozogamicin
    Mylotarg (gemtuzumab ozogamicin)
    Refractory Acute Myeloid Leukemia$PFE PFIZER INC
  • Phase 2
    genistein
    genistein
    Pulmonary Fibrosis Humanetics Corp
  • Marketed
    gentamicin sulfate
    Gentamicin Sulfate
    Bacterial Blepharoconjunctivitis Fera Pharmaceuticals LLC
  • Preclinical
    gentulizumab
    gentulizumab
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Changchun High-Tech Industry Group Co Ltd
  • Marketed
    gepirone hydrochloride ER
    Exxua (gepirone hydrochloride)
    Major Depressive Disorder Fabre-Kramer Pharmaceuticals Inc
  • Phase 2
    gilavebexagene anvuparvovec
    gilavebexagene anvuparvovec
    Tay-Sachs Disease University of Massachusetts
  • Phase 3
    gildeuretinol acetate
    gildeuretinol acetate
    Juvenile Macular Degeneration (Stargardt Disease) Alkeus Pharmaceuticals Inc
  • Marketed
    gilteritinib fumarate
    Xospata (gilteritinib fumarate)
    Refractory Acute Myeloid Leukemia Astellas Pharma US Inc
  • Phase 1
    gintemetostat tartrate
    gintemetostat tartrate
    Refractory Multiple Myeloma K36 Therapeutics Inc
  • pre_registration
    giredestrant
    giredestrant
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Genentech Inc
  • Marketed
    givinostat hydrochloride
    Duvyzat (givinostat hydrochloride)
    Polycythemia Vera Italfarmaco SpA
  • Marketed
    givosiran
    Givlaari (givosiran)
    Acute Intermittent Porphyria$ALNY ALNYLAM PHARMACEUTICALS, INC.
  • Marketed
    glacial acetic acid
    Acetic Acid
    Otitis Externa Sciegen Pharmaceuticals Inc
  • Marketed
    glasdegib
    Daurismo (glasdegib)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$PFE PFIZER INC
  • Phase 2
    glecirasib
    glecirasib [INN]
    Non-Small Cell Lung Cancer Jacobio Pharmaceuticals Group Co Ltd
  • Phase 3
    glenzocimab
    glenzocimab
    Acute Ischemic Stroke Acticor Biotech SAS
  • Marketed
    glimepiride
    Glimepiride
    Type 2 Diabetes Carlsbad Technology Inc
  • Marketed
    glipizide
    Glipizide
    Type 2 Diabetes Graviti Pharmaceuticals Inc
  • Marketed
    glucagon
    Gvoke (glucagon [INN])
    Hypoglycemia$XERS Xeris Biopharma Holdings, Inc.
  • Marketed
    glucarpidase
    Voraxaze (glucarpidase [INN])
    Chemotherapy Effects BTG International Inc
  • Phase 3
    glufosfamide
    glufosfamide [INN]
    Metastatic Adenocarcinoma of The Pancreas Eleison Pharmaceuticals Inc
  • Phase 3
    glyburide
    Cirara (glyburide)
    Diabetes$ETON Eton Pharmaceuticals, Inc.